Serum levels of transforming growth factor‐α in patients after partial hepatectomy as determined with an enzyme‐linked immunosorbent assay

Tomoaki Tomiya, Kenji Fujiwara – 1 August 1993 – A sandwich enzyme‐linked immunosorbent assay for measuring serum transforming growth factor‐α levels was developed with monoclonal IgM and polyclonal IgG antihuman transforming growth factor‐α antibodies and a system to amplify the activity of the conjugated enzyme. The assay detected serum transforming growth factor‐α levels as low as 5 pg/ml. Serum transforming growth factor‐α levels were below the detection limit of the assay in 19% of healthy adults, with a mean (± S.D.) detectable level of 22.0 ± 16.7 pg/ml.

Constipation: Is it a risk factor for cholesterol gallstones?

Jorge J. Gumucio, James L. Watkins, Thelma E. Wiley, Thomas J. Layden – 1 August 1993 – Many cases of gallstones can be explained in terms of the established risk factors, especially obesity. However, gallstones develop in some women who are not obese, and the causes are unknown. Biochemical studies have shown that slow intestinal transit is associated with lithogenic bile. We have tested the hypothesis that intestinal transit is abnormally slow in normal‐weight women with gallstones.

Effects of ritanserin, a selective and specific S2‐serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long‐term bile duct ligation

Mercedes Fernández, Pilar Pizcueta, Juan Carlos García‐Pagán, Faust Feu, Isabel Cirera, Jaime Bosch, Joan Rodés – 1 August 1993 – This study investigated the short‐term effects of ritanserin, a selective and specific S2‐serotonergic antagonist, in an experimental model of cirrhosis and intrahepatic portal hypertension caused by long‐term bile duct ligation and division and in normal control rats.

Nitric oxide mediates lipopolysaccharide‐induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver

Iwao Kurose, Shinzo Kato, Hiromasa Ishii, Dai Fukumura, Soichiro Miura, Makoto Suematsu, Masaharu Tsuchiy – 1 August 1993 – The influence of endogenous nitric oxide, which is generated by stimulation with lipopolysaccharide, on the mitochondrial energization of rat hepatocytes was investigated in vitro and ex vivo.

Isolation and enrichment of two sublobular compartment‐specific endothelial cell subpopulations from liver sinusoids

Fernando Vidal‐Vanaclocha, Marian Rocha, Aintzane Asumendi, Emilio Barberá‐Guillem – 1 August 1993 – Similar to the well‐recognized phenotypical heterogeneity of hepatocytes, in situ sublobular variations have recently been detected in the cell structure, fenestration patterns, filtrating efficiency, surface glycosylation, scavenger function and pathological responses of the sinusoidal lining endothelium.

Induced expression of heat‐shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis

Ulrika Broomé, Annika Scheynius, Rolf Hultcrantz – 1 August 1993 – In both primary sclerosing cholangitis and primary biliary cirrhosis it is supposed that immunological mechanisms are involved in the progressive destruction of the bile ducts. The aberrant expression of human leukocyte antigen‐DR in the bile ducts of patients with these disorders enables the biliary epithelium to present putative antigens to the surrounding lymphocytes; however, no such antigen has been identified. Heat‐shock proteins have been implicated in the pathogenesis of various immunological destructive disorders.

Levamisole and interferon in children with chronic hepatitis B

Mercedes Ruiz‐Moreno, Rosa García, Maria Jose Rua, Beatriz Serrano, Gloria Moraleda, Esperanza Feijoo, Javier Bartolomé, Fernando Ortiz, Inmaculada Castill, Vicente Carreñ – 1 August 1993 – To evaluate the possible usefulness of simultaneous administration of levamisole and interferon, we randomly allocated 38 children with chronic hepatitis B to receive either 10 MU/m2 interferon‐α‐2a, three times a week for 6 mo (group 1, n = 20) or 90 mg/m2 of levamisole for 45 days, together with 10 MU/m2 of interferon‐α‐2a, three times a week for 6 mo (group 2, n = 18).

Subscribe to